I PP2A 1 Affects Tau Phosphorylation via Association with the Catalytic Subunit of Protein Phosphatase 2A
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
In Alzheimer disease (AD) brain, the level of I (1)(PP2A), a 249-amino acid long endogenous inhibitor of protein phosphatase 2A (PP2A), is increased, the activity of the phosphatase is decreased, and the microtubule-associated protein Tau is abnormally hyperphosphorylated. However, little is known about the detailed regulatory mechanism by which PP2A activity is inhibited by I (1)(PP2A) and the consequent events in mammalian cells. In this study, we found that both I (1)(PP2A) and its N-terminal half I (1)(PP2A(1-120)), but neither I (1)(PP2A(1-163)) nor I (1)(PP2A(164-249)), inhibited PP2A activity in vitro, suggesting an autoinhibition by amino acid residues 121-163 and its neutralization by the C-terminal region. Furthermore, transfection of NIH3T3 cells produced a dose-dependent inhibition of PP2A activity by I (1)(PP2A)(1). I (PP2A) and PP2A were found to colocalize in PC12 cells. I (1)(PP2A) could only interact with the catalytic subunit of PP2A (PP2Ac) and had no interaction with the regulatory subunits of PP2A (PP2A-A or PP2A-B) using a glutathione S-transferase-pulldown assay. The interaction was further confirmed by coimmunoprecipitation of I (1)(PP2A) and PP2Ac from lysates of transiently transfected NIH3T3 cells. The N-terminal isotype specific region of I (1)(PP2A) was required for its association with PP2Ac as well as PP2A inhibition. In addition, the phosphorylation of Tau was significantly increased in PC12/Tau441 cells transiently transfected with full-length I (1)(PP2A) and with PP2Ac-interacting I (1)(PP2A) deletion mutant 1-120 (I (1)(PP2A)DeltaC2). Double immunofluorescence staining showed that I (1)(PP2A) and I (1)(PP2A)DeltaC2 increased Tau phosphorylation and impaired the microtubule network and neurite outgrowth in PC12 cells treated with nerve growth factor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Self-citationNeurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Observations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084
Tau pathology in Alzheimer disease and other tauopathies
Iqbal, K., del C. Alonso, A., Chen, S., Chohan, M. O., El-Akkad, E., Gong, C.-X., Khatoon, S., Li, B., Liu, F., Rahman, A., et al. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.09.008 · Cited by 1,037
O-GlcNAcylation regulates phosphorylation of tau: A mechanism involved in Alzheimer's disease
Liu, F., Iqbal, K., Grundke-Iqbal, I., Hart, G. W., & Gong, C.-X. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400348101 · Cited by 775
Self-citationRole of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease.
Alonso, A. C., Zaidi, T., Grundke-Iqbal, I., & Iqbal, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5562 · Cited by 738
Self-citationPhosphoprotein Phosphatase Activities in Alzheimer Disease Brain
Gong, C., Singh, T. J., Grundke‐Iqbal, I., & Iqbal, K. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03603.x · Cited by 527
Self-citationAlonso, A. D. C., Grundke-Iqbal, I., Barra, H. S., & Iqbal, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.298 · Cited by 437
Self-citationBraak, H., Braak, E., Grundke-Iqbal, I., & Iqbal, K. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90288-0 · Cited by 432
Self-citationPP2A mRNA Expression Is Quantitatively Decreased in Alzheimer's Disease Hippocampus
Vogelsberg-Ragaglia, V., Schuck, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7630 · Cited by 281
Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer’s disease
Tanimukai, H., Grundke-Iqbal, I., & Iqbal, K. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62486-8 · Cited by 220
Self-citationPolymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity
Alonso, A. D. C., Li, B., Grundke-Iqbal, I., & Iqbal, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603214103 · Cited by 206
Self-citationBennecib, M., Gong, C.-X., Grundke-Iqbal, I., & Iqbal, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02203-1 · Cited by 184
Kins, S., Kurosinski, P., Nitsch, R. M., & Götz, J. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63444-x · Cited by 155
Tsujio, I., Zaidi, T., Xu, J., Kotula, L., Grundke-Iqbal, I., & Iqbal, K. (2005) · FEBS Letters · doi:10.1016/j.febslet.2004.11.097 · Cited by 80
Self-citation
Research works printed but not linked: 49
- Cohen, 1989, Annu. Rev. Biochem., 58, 453, 10.1146/annurev.bi.58.070189.002321 · DOI · Paper page
- Iqbal, K., Alonso, A., Gong, C., Khatoon, S., Pei, J. J., Wang, J. Z., and Grundke-Iqbal, I. (1997) in Brain Microtubule Associated Proteins: Modifications and Disease (Kosik, K., and Avila, J., eds) pp. 95–111, Harwood Academic Publishers, New York
- Gong, 1994, Neuroscience, 61, 765, 10.1016/0306-4522(94)90400-6 · DOI
- Liu, 2005, Eur. J. Neurosci., 22, 1942, 10.1111/j.1460-9568.2005.04391.x · DOI · Paper page
- Iqbal, 1998, J. Neural. Transm. Suppl., 53, 169, 10.1007/978-3-7091-6467-9_15 · DOI
- Bennecib, 2000, Alzheimer's Rep., 3, 295
- Sontag, 1996, Neuron, 17, 1201, 10.1016/S0896-6273(00)80250-0 · DOI · Paper page
- Sontag, 1999, J. Biol. Chem., 274, 25490, 10.1074/jbc.274.36.25490 · DOI · Paper page
- Gong, 2000, Brain Res., 853, 299, 10.1016/S0006-8993(99)02294-5 · DOI
- Li, 2004, FEBS Lett., 566, 261, 10.1016/j.febslet.2004.04.047 · DOI · Paper page
- Pei, 2003, Am. J. Pathol., 163, 845, 10.1016/S0002-9440(10)63445-1 · DOI
- Virshup, 2000, Curr. Opin Cell Biol., 12, 180, 10.1016/S0955-0674(99)00074-5 · DOI · Paper page
- Li, 1995, Biochemistry, 34, 1988, 10.1021/bi00006a020 · DOI · Paper page
- Li, 1996, Biochemistry, 35, 6998, 10.1021/bi960581y · DOI · Paper page
- Chen, 1996, Mol. Biol. Cell, 7, 2045, 10.1091/mbc.7.12.2045 · DOI · Paper page
- Matsuoka, 1994, Proc. Natl. Acad. Sci. U. S. A., 91, 9670, 10.1073/pnas.91.21.9670 · DOI · Paper page
- Mencinger, 1998, Biochim. Biophys. Acta, 1395, 176, 10.1016/S0167-4781(97)00165-6 · DOI
- Ulitzur, 1997, Proc. Natl. Acad. Sci. U. S. A., 94, 5084, 10.1073/pnas.94.10.5084 · DOI
- Vaesen, 1994, Biol. Chem. Hoppe. Seyler., 375, 113, 10.1515/bchm3.1994.375.2.113 · DOI · Paper page
- Walensky, 1993, Cancer Res., 53, 4720
- Yu, 2004, J. Biol. Chem., 279, 41377, 10.1074/jbc.M400017200 · DOI
- Matilla, 2005, Cerebellum, 4, 7, 10.1080/14734220410019020 · DOI
- Hasegawa, 1993, J. Neurochem., 60, 2068, 10.1111/j.1471-4159.1993.tb03491.x · DOI · Paper page
- Seubert, 1995, J. Biol. Chem., 270, 18917, 10.1074/jbc.270.32.18917 · DOI · Paper page
- Tanimukai, 2004, Brain Res. Mol. Brain Res., 126, 146, 10.1016/j.molbrainres.2004.04.003 · DOI
- Kutney, 2004, J. Biol. Chem., 279, 30850, 10.1074/jbc.M404969200 · DOI
- Seo, 2002, J. Biol. Chem., 277, 14005, 10.1074/jbc.M112455200 · DOI
- Brennan, 2000, J. Cell Biol., 151, 1, 10.1083/jcb.151.1.1 · DOI · Paper page
- Gong, 1995, J. Neurochem., 65, 732, 10.1046/j.1471-4159.1995.65020732.x · DOI · Paper page
- Goedert, 1995, J. Neurochem., 65, 2804, 10.1046/j.1471-4159.1995.65062804.x · DOI · Paper page
- Tanaka, 1998, FEBS Lett., 426, 248, 10.1016/S0014-5793(98)00346-9 · DOI · Paper page
- Tolnay, 1999, Neuropathol. Appl. Neurobiol., 25, 171, 10.1046/j.1365-2990.1999.00182.x · DOI · Paper page
- Alafuzoff, 1987, ActaNeuropathol. (Berl.), 74, 209, 10.1007/BF00688184 · DOI · Paper page
- Iqbal, 1986, Lancet, 2, 421, 10.1016/S0140-6736(86)92134-3 · DOI · Paper page
- Liu, 2004, J. Biol. Chem., 279, 50078, 10.1074/jbc.M406109200 · DOI · Paper page
- Santacruz, 2005, Science, 309, 476, 10.1126/science.1113694 · DOI · Paper page
- Li, 2007, Acta Neuropathol. (Berl.), 113, 501, 10.1007/s00401-007-0207-8 · DOI · Paper page
- Gong, 2000, J. Biol. Chem., 275, 5535, 10.1074/jbc.275.8.5535 · DOI · Paper page
- Sontag, 2004, J. Neuropathol. Exp. Neurol., 63, 287, 10.1093/jnen/63.4.287 · DOI · Paper page
- Loring, 2001, DNA Cell Biol., 20, 683, 10.1089/10445490152717541 · DOI · Paper page
- Ulitzur, 1997, J. Biol. Chem., 272, 30577, 10.1074/jbc.272.48.30577 · DOI · Paper page
- Opal, 2003, J. Biol. Chem., 278, 34691, 10.1074/jbc.M302785200 · DOI · Paper page
- Hong, 2004, Biochemistry, 43, 10157, 10.1021/bi0493968 · DOI
- Wang, 2007, Eur. J. Neurosci., 25, 59, 10.1111/j.1460-9568.2006.05226.x · DOI · Paper page
- Alonso, 2001, Proc. Natl. Acad. Sci. U. S. A., 98, 6923, 10.1073/pnas.121119298 · DOI · Paper page
- Wang, 1996, Brain Res. Mol. Brain Res., 38, 200, 10.1016/0169-328X(95)00316-K · DOI
- Pei, 2003, Acta Neuropathol. (Berl.), 105, 381, 10.1007/s00401-002-0657-y · DOI · Paper page
- Sengupta, 2006, FEBS Lett., 580, 5925, 10.1016/j.febslet.2006.09.060 · DOI · Paper page
- Alonso, 1996, Nat. Med., 2, 783, 10.1038/nm0796-783 · DOI · Paper page
Cited by
Tau in physiology and pathology
Wang, Y., & Mandelkow, E. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.1 · Cited by 2,251
Post-translational modifications of tau protein: Implications for Alzheimer's disease
Martin, L., Latypova, X., & Terro, F. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2010.12.023 · Cited by 641
Mechanisms of tau-induced neurodegeneration
Iqbal, K., Liu, F., Gong, C.-X., Alonso, A. D. C., & Grundke-Iqbal, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0486-3 · Cited by 628
Self-citationXiong, Y., Jing, X.-P., Zhou, X.-W., Wang, X.-L., Yang, Y., Sun, X.-Y., Qiu, M., Cao, F.-Y., Lu, Y.-M., Liu, R., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.07.003 · Cited by 122
Further understanding of tau phosphorylation: implications for therapy
Medina, M., & Avila, J. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1000864 · Cited by 41
“Tau phosphorylation inhibition can also be achieved by some PP2A regulators, thus unveiling new potential therapeutic targets such as PP2A inhibitors [56,57], the prolyl isomerase Pin1 [58] or PP2A methylation [59,60].”
Background
Metadata
- Authors
- Chen, S., Li, B., Grundke-Iqbal, I., & Iqbal, K.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2008-04
- Volume
- 283
- Issue
- 16
- Pages
- 10513-10521
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2041528500
- Cited by
- 84
- References
- 15
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4561 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.